Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Hiroaki Okushin"'
Autor:
Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe, Yukio Osaki, Kouji Joko, Hitoshi Yagisawa, Shinya Sakita, Hiroaki Okushin, Takashi Satou, Hiroyuki Hisai, Takehiko Abe, Keiji Tsuji, Takashi Tamada, Haruhiko Kobashi, Akeri Mitsuda, Yasushi Ide, Chikara Ogawa, Syotaro Tsuruta, Kouichi Takaguchi, Miyako Murakawa, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165339 (2016)
We aimed to clarify the characteristics of resistance-associated substitutions (RASs) after treatment failure with NS5A inhibitor, daclatasvir (DCV) in combination with NS3/4A inhibitor, asunaprevir (ASV), in patients with chronic hepatitis C virus g
Externí odkaz:
https://doaj.org/article/b9240e38227148be9226cb4333c32437
Autor:
Kazuhiko Morii, Takashi Oda, Hitomi Satoh, Yuka Kimura, Yuhki Aoyama, Yuki Fujiwara, Yasushi Hiramatsu, Hiroaki Okushin, Koich Uesaka, Shinichiro Nakamura
Publikováno v:
International Journal of Infectious Diseases, Vol 30, Iss C, Pp 148-149 (2015)
Externí odkaz:
https://doaj.org/article/aa665806d3b2426d91156dcfbf972c63
Autor:
Shigeru Mikami, Toshifumi Tada, Takashi Kumada, Shinichi Fujioka, Kazufumi Dohmen, Soo Ryang Kim, Tsutomu Tamai, Soo Ki Kim, Atsushi Hiraoka, Kunihiko Tsuji, Akemi Tsutsui, Kazuhiro Nouso, Hiroaki Okushin, Michitaka Imai, Ei Itobayashi, Toru Ishikawa, Yuto Watanabe, Kojiro Michitaka, Kazuya Kariyama, Hironori Tanaka, Joji Tani, Koichi Takaguchi, Masanori Atsukawa, Norio Itokawa, Hidenori Toyoda, Noritomo Shimada, Satoshi Yasuda, Hiroshi Shibata
Publikováno v:
Infectious Diseases and Therapy
Introduction The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) were assessed in patients who were chronically infected with hepatitis C virus (HCV) geno
Publikováno v:
Internal Medicine
Objective An infectious hepatic cyst (IHC) is a hepatic cyst complicated with secondary infection and is generally assumed to be rare. However, we have experienced no small number of patients with IHC in recent clinical practice. We therefore examine
Autor:
Shiso Sato, Hiroaki Okushin, Shinichiro Nakamura, Riku Uematsu, Kyohei Kai, Takeharu Yamamoto, Takanori Watanabe, Noriyuki Nishiwaki, Kazuhiko Morii
Publikováno v:
Internal Medicine
A 76-year-old woman with hereditary hemorrhagic telangiectasia (HHT) showed elevated serum hepatobiliary enzyme levels, and abdominal imaging studies revealed a hepatic tumor. Her serum alpha-fetoprotein level was 759.5 ng/mL. A pathological examinat
Autor:
Jun Itakura, Chikara Ogawa, Atsunori Kusakabe, Akihiro Nasu, Kouji Joko, Masayuki Kurosaki, Hideki Fujii, Yuji Kojima, Masahiko Kondo, Keiji Tsuji, Takehiro Akahane, Hiroyuki Kimura, Haruhiko Kobashi, Keizo Kato, Chitomi Hasebe, Tetsuro Sohda, Yasushi Ide, Akeri Mitsuda, Hiroaki Okushin, Tamada T, Takashi Satou, Namiki Izumi, Hideo Yoshida, Shinya Sakita, Yasushi Uchida, Kazuhiko Okada, Atsuhiro Morita, Hitoshi Yagisawa
Publikováno v:
Hepatology Research. 48:746-756
Aim To evaluate the virologic responses and clinical course of daclatasvir plus asunaprevir treatment in non-hemodialysis (non-HD) and hemodialysis (HD) patients infected with genotype 1 hepatitis C virus (HCV). Methods A total of 1113 non-HD patient
Autor:
Yuri, Harayama, Kazuhiko, Morii, Mutsuko, Kuribayashi, Ryunosuke, Takechi, Shogo, Yonehara, Kazuya, Matsumoto, Takuro, Masuda, Takeharu, Yamamoto, Shinichiro, Nakamura, Hiroaki, Okushin
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 116(7)
Cirrhotic cardiomyopathy (CCM) is a chronic cardiac dysfunction in patients with cirrhosis and is characterized by altered diastolic relaxation, blunted contractile response to stress, and electrophysiological abnormalities;however, causes of CCM are
Autor:
Chikara Ogawa, Hiroyuki Kimura, Tomomichi Matsushita, Keiji Tsuji, Akeri Mitsuda, Kazuhiko Okada, Koichiro Furuta, Chiharu Kawanami, Kouji Joko, Haruhiko Kobashi, Toshie Mashiba, Atsuhiro Morita, Yasushi Ide, Chitomi Hasebe, Hiroaki Okushin, Hiroshi Ito, Tetsuro Sohda, Masayuki Kurosaki, Takashi Satou, Ryo Nakata, Tamada T, Namiki Izumi, Atsunori Kusakabe, Ryoichi Narita, Takehiro Akahane, Masaya Shigeno, Hitoshi Yagisawa, Hironori Ochi
Publikováno v:
Hepatology Research
AIM The present study aimed to determine the real-world efficacy and safety of the non-structural protein (NS)5A inhibitor elbasvir (EBR) combined with the NS3/4A protease inhibitor grazoprevir (GZR) in patients with hepatitis C virus (HCV) genotype
Publikováno v:
Geriatrics & Gerontology International. 17:1722-1728
Aim Autoimmune hepatitis (AIH) commonly shows bimodal distribution of onset age: at young adulthood and at 50-60 years-of-age. However, in recent times, the incidence of elderly-onset AIH seems to be increasing. This study aimed to investigate whethe
Publikováno v:
Gastroenterology & Hepatology: Open Access. 8